Clinical Trials in New York

Showing 20141-20160 of 22,668 trials

UNKNOWN< 1 mile

Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome

NCT01893619

Observational study regarding the use of supplements in chronic fatigue syndrome patients

Chronic Fatigue Syndrome

New York CFS Association100 participantsStarted Jun 2013

New York, New York, United States

COMPLETEDPhase 1< 1 mile

Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer

NCT00858663

The purpose of this study is to determine the best doses of RAD001 (everolimus) tablets and cisplatin to give to patients who are receiving radiation therapy for head and neck cancer.

Head and Neck Cancer

Memorial Sloan Kettering Cancer Center13 participantsStarted Mar 2009

New York, New York, United States

Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome

Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer

Find Trials by Condition in New York

Use of a Monitor in ME/CFS

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma

Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP

3-AP in Treating Patients With Advanced Cancer

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

Aminocamptothecin in Treating Patients With T-cell Lymphoma

3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia